Considering that α-synuclein aggregates act as ligands for TLR2 [26], it is possible that alterations in intestinal microbiota and increased accumulation of α-synuclein aggregates might lead to TLR2 activation, contributing to PD pathogenesis. This evidence concerns the gene SNCA and Parkinson disease.